Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact 000110281320 cql: author exact 001996200988

Add to list
- Journal Article
- A1
- open access
Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, An M. T. Van Nuffel, Ann Belmans, Kris Bogaerts, Regina Baiden-Amissah, Lien Lippens (UGent) , Peter Vuylsteke, Stéphanie Henry, Xuan Bich Trinh, et al.

(2023) CANCER IMMUNOLOGY IMMUNOTHERAPY. 72(2). p.475-491
Add to list
- Journal Article
- A1
- open access
Association of cell death markers with tumor immune cell infiltrates after chemo-radiation in cervical cancer

Teodora-Eugenia Oltean (UGent) , Lien Lippens (UGent) , Kelly Lemeire (UGent) , Caroline De Tender (UGent) , Marnik Vuylsteke, Hannelore Denys (UGent) , Katrien Vandecasteele (UGent) , Peter Vandenabeele (UGent) and Sandy Adjemian Catani (UGent)

(2022) FRONTIERS IN ONCOLOGY. 12.
Add to list
- Conference Paper
- C3
Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Emiel De Jaeghere (UGent) , Sandra Tuyaerts, Ann M.T. Van Nuffel, Lien Lippens (UGent) , An Hendrix (UGent) , P. Vuylsteke, S. Henry, X.B. Trinh, P.A. Van Dam, S. Aspeslagh, et al.

(2021) ANNALS OF ONCOLOGY. In Annals of Oncology 32(Supplement 7). p.S1449-S1450
Add to list
- Journal Article
- A1
- open access
Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction

Joeri Tulkens, Glenn Vergauwen (UGent) , Jan Van Deun (UGent) , Edward Geeurickx, Bert Dhondt (UGent) , Lien Lippens (UGent) , Marie-Angélique De Scheerder (UGent) , Ilkka Miinalainen, Pekka Rappu, Bruno De Geest (UGent) , et al.

(2020) GUT. 69(1). p.191-193
Add to list
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment

Lien Lippens (UGent) , Mieke Van Bockstal (UGent) , Emiel De Jaeghere (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , Sofie De Geyter (UGent) , Koen Van de Vijver (UGent) , An Hendrix (UGent) , Katrien Vandecasteele (UGent) and Hannelore Denys (UGent)

(2020) International Journal of Cancer.
Add to list
Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Emiel De Jaeghere (UGent) , Frederiek Laloo, Lien Lippens (UGent) , Mieke Van Bockstal (UGent) , Kathia De Man (UGent) , Eline Naert (UGent) , Jo Van Dorpe (UGent) , Koen Van de Vijver (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , et al.

(2020) GYNECOLOGIC ONCOLOGY. 159(2). p.335-343
Add to list
- Conference Paper
- C3
Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment

Lien Lippens (UGent) , Mieke Van Bockstal (UGent) , Emiel De Jaeghere (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , Sofie De Geyter (UGent) , Koen Van de Vijver (UGent) , An Hendrix (UGent) , Katrien Vandecasteele (UGent) and Hannelore Denys (UGent)

(2019) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 29. p.A117-A117
Add to list
- Conference Paper
- C3
Splenic metabolic activity as biomarker in cervical cancer

Emiel De Jaeghere (UGent) , Frederiek Laloo, Lien Lippens (UGent) , Kathia De Man (UGent) , Mieke Van Bockstal, Koen Van de Vijver (UGent) , Philippe Tummers (UGent) , Amin Makar (UGent) , Pieter De Visschere (UGent) , Olivier De Wever (UGent) , et al.

(2019) ANNALS OF ONCOLOGY. 30(5).
Add to list
- Journal Article
- A1
- open access
PRIMMO study protocol : a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

Sandra Tuyaerts, An MT Van Nuffel, Eline Naert (UGent) , Peter A Van Dam, Peter Vuylsteke, Alex De Caluwé, Sandrine Aspeslagh, Piet Dirix, Lien Lippens (UGent) , Emiel De Jaeghere (UGent) , et al.

(2019) BMC CANCER. 19.
Add to list
- Conference Paper
- C3
The small GTPase Rab27B stimulates secretion of a subpopulation of ARRDC1-positive small extracellular vesicles (SEV)

Lien Lippens (UGent) , Robin Boiy (UGent) , Bert Dhondt (UGent) , Bruno De Geest (UGent) , Katrien Vandecasteele (UGent) , Hannelore Denys (UGent) , Olivier De Wever (UGent) and An Hendrix (UGent)

(2018) OncoPoint, 6th Research seminar, Abstracts.

Academic Bibliography

Pembrolizumab, radiotherapy, and an immunomodulatory five-drug cocktail in pretreated patients with persistent, recurrent, or metastatic cervical or endometrial carcinoma : results of the phase II PRIMMO study

Association of cell death markers with tumor immune cell infiltrates after chemo-radiation in cervical cancer

Pembrolizumab, SBRT, and immunomodulation for recurrent and/or refractory cervical or endometrial carcinoma

Increased levels of systemic LPS-positive bacterial extracellular vesicles in patients with intestinal barrier dysfunction

Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment

Splenic 18F-FDG uptake on baseline PET/CT is associated with oncological outcomes and tumor immune state in uterine cervical cancer

Immunologic impact of chemoradiation in cervical cancer and how immune cell infiltration could lead towards personalized treatment

Splenic metabolic activity as biomarker in cervical cancer

PRIMMO study protocol : a phase II study combining PD-1 blockade, radiation and immunomodulation to tackle cervical and uterine cancer

The small GTPase Rab27B stimulates secretion of a subpopulation of ARRDC1-positive small extracellular vesicles (SEV)

Contents

Support

Contact